Symbol="CRVS"
AssetType="Common Stock"
Name="Corvus Pharmaceuticals Inc"
Description="Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is headquartered in Burlingame, California."
CIK="1626971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="111648000"
EBITDA="-30892000"
PERatio="None"
PEGRatio="0"
BookValue="1.049"
DividendPerShare="0"
DividendYield="0"
EPS="-0.78"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.245"
ReturnOnEquityTTM="-0.59"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.576"
EVToRevenue="-"
EVToEBITDA="0.265"
Beta="0.975"
num_52WeekHigh="4.19"
num_52WeekLow="0.607"
num_50DayMovingAverage="2.621"
num_200DayMovingAverage="1.424"
SharesOutstanding="46568500"
DividendDate="None"
ExDividendDate="None"
symbol="CRVS"
open="2.15"
high="2.43"
low="2.14"
price="2.31"
volume="382527.00"
latest_trading_day="2023-08-09"
previous_close="2.14"
change="0.17"
change_percent="7.9439%"
aroon_positive_momentum_days="89"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="89"
Volume_recent_avg="826561"
Change_recent_avg="0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="89"
Aroon_momentum_negative="11"
image_negative_thumbnail_id_1="1096"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="1015"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_positive_thumbnail_id_2="681"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0027.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
